{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:44:37Z","timestamp":1789789477041,"version":"4.0.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Nanjing Health Science and Technology Development Special Fund","award":["M2021073"],"award-info":[{"award-number":["M2021073"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11227-4","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:30:25Z","timestamp":1751373025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Nanopore-based targeted sequencing (NTS) for drug-resistant tuberculosis: an integrated tool for personalized treatment strategies and guidance for new drug development"],"prefix":"10.1186","volume":"25","author":[{"given":"Chen","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangchuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianzhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"10","key":"11227_CR1","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41579-024-01025-1","volume":"22","author":"M Farhat","year":"2024","unstructured":"Farhat M, Cox H, Ghanem M, Denkinger CM, Rodrigues C, Abd El Aziz MS, Enkh-Amgalan H, Vambe D, Ugarte-Gil C, Furin J, et al. Drug-resistant tuberculosis: a persistent global health concern. Nat Rev Microbiol. 2024;22(10):617\u201335.","journal-title":"Nat Rev Microbiol"},{"key":"11227_CR2","unstructured":"Global. tuberculosis report 2024 [https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2024]"},{"issue":"4","key":"11227_CR3","doi-asserted-by":"publisher","first-page":"e0018019","DOI":"10.1128\/cmr.00180-19","volume":"35","author":"N Dookie","year":"2022","unstructured":"Dookie N, Ngema SL, Perumal R, Naicker N, Padayatchi N, Naidoo K. The changing paradigm of Drug-Resistant tuberculosis treatment: successes, pitfalls, and future perspectives. Clin Microbiol Rev. 2022;35(4):e0018019.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"11227_CR4","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1016\/S1473-3099(22)00875-1","volume":"23","author":"J Dom\u00ednguez","year":"2023","unstructured":"Dom\u00ednguez J, Boeree MJ, Cambau E, Chesov D, Conradie F, Cox V, Dheda K, Dudnyk A, Farhat MR, Gagneux S, et al. Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet\/RESIST-TB consensus statement. Lancet Infect Dis. 2023;23(4):e122\u201337.","journal-title":"Lancet Infect Dis"},{"key":"11227_CR5","doi-asserted-by":"publisher","first-page":"102522","DOI":"10.1016\/j.tube.2024.102522","volume":"148","author":"A Sanchini","year":"2024","unstructured":"Sanchini A, Lanni A, Giannoni F, Mustazzolu A. Exploring diagnostic methods for drug-resistant tuberculosis: A comprehensive overview. Tuberculosis (Edinb). 2024;148:102522.","journal-title":"Tuberculosis (Edinb)"},{"issue":"2","key":"11227_CR6","first-page":"176","volume":"46","author":"C Liang","year":"2023","unstructured":"Liang C, Tang SJ. [Annual progress on molecular biological diagnosis of tuberculosis 2022]. Zhonghua Jie He He Hu Xi Za Zhi. 2023;46(2):176\u201382.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"6","key":"11227_CR7","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/clinchem\/hvaa092","volume":"66","author":"K Tafess","year":"2020","unstructured":"Tafess K, Ng TTL, Lao HY, Leung KSS, Tam KKG, Rajwani R, Tam STY, Ho LPK, Chu CMK, Gonzalez D, et al. Targeted-Sequencing workflows for comprehensive drug resistance profiling of Mycobacterium tuberculosis cultures using two commercial sequencing platforms: comparison of analytical and diagnostic performance, turnaround time, and cost. Clin Chem. 2020;66(6):809\u201320.","journal-title":"Clin Chem"},{"issue":"5","key":"11227_CR8","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1007\/s11033-020-05413-7","volume":"47","author":"B Acharya","year":"2020","unstructured":"Acharya B, Acharya A, Gautam S, Ghimire SP, Mishra G, Parajuli N, Sapkota B. Advances in diagnosis of tuberculosis: an update into molecular diagnosis of Mycobacterium tuberculosis. Mol Biol Rep. 2020;47(5):4065\u201375.","journal-title":"Mol Biol Rep"},{"issue":"3","key":"11227_CR9","doi-asserted-by":"publisher","first-page":"e0259610","DOI":"10.1371\/journal.pone.0259610","volume":"17","author":"E Tamanaha","year":"2022","unstructured":"Tamanaha E, Zhang Y, Tanner NA. Profiling RT-LAMP tolerance of sequence variation for SARS-CoV-2 RNA detection. PLoS ONE. 2022;17(3):e0259610.","journal-title":"PLoS ONE"},{"issue":"3","key":"11227_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.4103\/ijmy.ijmy_202_23","volume":"13","author":"ZM Mwangi","year":"2024","unstructured":"Mwangi ZM, Ireri S, Opwaka H, Otieno L, Simam J, Onyambu FG, Mukiri N. Diagnostic accuracy of fluorocycler XT MTBDR assay for detection of rifampicin and Isoniazid-resistant mycobacteria tuberculosis in clinical isolates from Kenya. Int J Mycobacteriol. 2024;13(3):258\u201364.","journal-title":"Int J Mycobacteriol"},{"key":"11227_CR11","doi-asserted-by":"crossref","unstructured":"Beviere M, Reissier S, Penven M, Dejoies L, Guerin F, Cattoir V, Piau C. The role of Next-Generation sequencing (NGS) in the management of tuberculosis: practical review for implementation in routine. Pathogens 2023, 12(8).","DOI":"10.3390\/pathogens12080978"},{"key":"11227_CR12","doi-asserted-by":"crossref","unstructured":"Chen Q, Yi J, Liu Y, Yang C, Sun Y, Du J, Liu Y, Gu D, Liu H, Xu Y et al. Clinical diagnostic value of targeted next\u2013generation sequencing for infectious diseases (Review). Mol Med Rep 2024, 30(3).","DOI":"10.3892\/mmr.2024.13277"},{"issue":"12","key":"11227_CR13","doi-asserted-by":"publisher","first-page":"e0277145","DOI":"10.1371\/journal.pone.0277145","volume":"17","author":"GT Akalu","year":"2022","unstructured":"Akalu GT, Tessema B, Petros B. High proportion of RR-TB and mutations conferring RR outside of the RRDR of the RpoB gene detected in GeneXpert MTB\/RIF assay positive pulmonary tuberculosis cases, in addis ababa, Ethiopia. PLoS ONE. 2022;17(12):e0277145.","journal-title":"PLoS ONE"},{"issue":"1","key":"11227_CR14","doi-asserted-by":"publisher","first-page":"2392656","DOI":"10.1080\/22221751.2024.2392656","volume":"13","author":"MKM Uddin","year":"2024","unstructured":"Uddin MKM, Cabibbe AM, Nasrin R, Ghodousi A, Nobel FA, Rahman SMM, Ahmed S, Ather MF, Razzaque SMA, Raihan MA, et al. Targeted next-generation sequencing of Mycobacterium tuberculosis from patient samples: lessons learned from high drug-resistant burden clinical settings in Bangladesh. Emerg Microbes Infect. 2024;13(1):2392656.","journal-title":"Emerg Microbes Infect"},{"key":"11227_CR15","doi-asserted-by":"crossref","unstructured":"Colman RE, Seifert M, De la Rossa A, Georghiou SB, Hoogland C, Uplekar S, Laurent S, Rodrigues C, Kambli P, Tukvadze N et al. Evaluating culture-free targeted next-generation sequencing for diagnosing drug-resistant tuberculosis: a multicentre clinical study of two end-to-end commercial workflows. Lancet Infect Dis 2024.","DOI":"10.1016\/S1473-3099(24)00586-3"},{"key":"11227_CR16","doi-asserted-by":"publisher","first-page":"102051","DOI":"10.1016\/j.tube.2021.102051","volume":"127","author":"P Kambli","year":"2021","unstructured":"Kambli P, Ajbani K, Kazi M, Sadani M, Naik S, Shetty A, Tornheim JA, Singh H, Rodrigues C. Targeted next generation sequencing directly from sputum for comprehensive genetic information on drug resistant Mycobacterium tuberculosis. Tuberculosis (Edinb). 2021;127:102051.","journal-title":"Tuberculosis (Edinb)"},{"issue":"6","key":"11227_CR17","doi-asserted-by":"publisher","first-page":"e0260522","DOI":"10.1128\/spectrum.02605-22","volume":"10","author":"SH Wu","year":"2022","unstructured":"Wu SH, Xiao YX, Hsiao HC, Jou R. Development and assessment of a novel Whole-Gene-Based targeted Next-Generation sequencing assay for detecting the susceptibility of Mycobacterium tuberculosis to 14 drugs. Microbiol Spectr. 2022;10(6):e0260522.","journal-title":"Microbiol Spectr"},{"key":"11227_CR18","unstructured":"Use of targeted. next-generation sequencing to detect drug-resistant tuberculosis [https:\/\/www.who.int\/publications\/i\/item\/9789240076372]"},{"key":"11227_CR19","doi-asserted-by":"publisher","first-page":"1349715","DOI":"10.3389\/fmicb.2024.1349715","volume":"15","author":"A Liu","year":"2024","unstructured":"Liu A, Liu S, Lv K, Zhu Q, Wen J, Li J, Liang C, Huang X, Gong C, Sun Q, et al. Rapid detection of multidrug resistance in tuberculosis using nanopore-based targeted next-generation sequencing: a multicenter, double-blind study. Front Microbiol. 2024;15:1349715.","journal-title":"Front Microbiol"},{"key":"11227_CR20","doi-asserted-by":"crossref","unstructured":"Wu X, Tan G, Sun C, Wang Y, Yang J, Wu C, Hu C, Yu F. Targeted next-generation sequencing - a promising approach in the diagnosis of Mycobacterium tuberculosis and drug resistance. Infection 2024.","DOI":"10.1007\/s15010-024-02411-w"},{"issue":"4","key":"11227_CR21","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/iub.2455","volume":"73","author":"SD Yelamanchi","year":"2021","unstructured":"Yelamanchi SD, Surolia A. Targeting amino acid metabolism of Mycobacterium tuberculosis for developing inhibitors to curtail its survival. IUBMB Life. 2021;73(4):643\u201358.","journal-title":"IUBMB Life"},{"issue":"5","key":"11227_CR22","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1021\/acsinfecdis.7b00255","volume":"4","author":"S Wellington","year":"2018","unstructured":"Wellington S, Hung DT. The expanding diversity of Mycobacterium tuberculosis drug targets. ACS Infect Dis. 2018;4(5):696\u2013714.","journal-title":"ACS Infect Dis"},{"issue":"6","key":"11227_CR23","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.cell.2013.10.045","volume":"155","author":"YJ Zhang","year":"2013","unstructured":"Zhang YJ, Reddy MC, Ioerger TR, Rothchild AC, Dartois V, Schuster BM, Trauner A, Wallis D, Galaviz S, Huttenhower C, et al. Tryptophan biosynthesis protects mycobacteria from CD4 T-cell-mediated killing. Cell. 2013;155(6):1296\u2013308.","journal-title":"Cell"},{"key":"11227_CR24","doi-asserted-by":"crossref","unstructured":"Guida M, Tammaro C, Quaranta M, Salvucci B, Biava M, Poce G, Consalvi S. Amino acid biosynthesis inhibitors in tuberculosis drug discovery. Pharmaceutics 2024, 16(6).","DOI":"10.3390\/pharmaceutics16060725"},{"key":"11227_CR25","doi-asserted-by":"crossref","unstructured":"Dheda K, Mirzayev F, Cirillo DM, Udwadia Z, Dooley KE, Chang KC, Omar SV, Reuter A, Perumal T, Horsburgh CR, editors. Jr.: Multidrug-resistant tuberculosis. Nat Rev Dis Primers. 2024;10(1):22.","DOI":"10.1038\/s41572-024-00504-2"},{"issue":"Suppl 1","key":"11227_CR26","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.ijid.2022.03.026","volume":"124","author":"S Tiberi","year":"2022","unstructured":"Tiberi S, Utjesanovic N, Galvin J, Centis R, D\u2019Ambrosio L, van den Boom M, Zumla A, Migliori GB. Drug resistant TB - latest developments in epidemiology, diagnostics and management. Int J Infect Dis. 2022;124(Suppl 1):S20\u20135.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"11227_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.5588\/pha.22.0041","volume":"13","author":"A Iyer","year":"2023","unstructured":"Iyer A, Ndlovu Z, Sharma J, Mansoor H, Bharati M, Kolan S, Morales M, Das M, Issakidis P, Ferlazzo G, et al. Operationalising targeted next-generation sequencing for routine diagnosis of drug-resistant TB. Public Health Action. 2023;13(2):43\u20139.","journal-title":"Public Health Action"},{"issue":"5","key":"11227_CR28","doi-asserted-by":"publisher","first-page":"e0409823","DOI":"10.1128\/spectrum.04098-23","volume":"12","author":"H Zhang","year":"2024","unstructured":"Zhang H, Dai X, Hu P, Tian L, Li C, Ding B, Yang X, He X. Comparison of targeted next-generation sequencing and the Xpert MTB\/RIF assay for detection of Mycobacterium tuberculosis in clinical isolates and sputum specimens. Microbiol Spectr. 2024;12(5):e0409823.","journal-title":"Microbiol Spectr"},{"key":"11227_CR29","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jgar.2024.05.018","volume":"38","author":"C Jin","year":"2024","unstructured":"Jin C, Wu Y, Chen J, Liu J, Zhang H, Qian Q, Pang T. Prevalence and patterns of drug-resistant Mycobacterium tuberculosis in newly diagnosed patients in china: A systematic review and meta-analysis. J Glob Antimicrob Resist. 2024;38:292\u2013301.","journal-title":"J Glob Antimicrob Resist"},{"issue":"4","key":"11227_CR30","doi-asserted-by":"publisher","first-page":"e0009324","DOI":"10.1371\/journal.pntd.0009324","volume":"15","author":"R Dai","year":"2021","unstructured":"Dai R, He J, Zha X, Wang Y, Zhang X, Gao H, Yang X, Li J, Xin Y, Wang Y, et al. A novel mechanism of streptomycin resistance in Yersinia pestis: mutation in the RpsL gene. PLoS Negl Trop Dis. 2021;15(4):e0009324.","journal-title":"PLoS Negl Trop Dis"},{"key":"11227_CR31","doi-asserted-by":"crossref","unstructured":"Lee C, Ye Q, Shin E, Ting T, Lee SJ. Acquisition of streptomycin resistance by oxidative stress induced by hydrogen peroxide in Radiation-Resistant bacterium Deinococcus geothermalis. Int J Mol Sci 2022, 23(17).","DOI":"10.3390\/ijms23179764"},{"issue":"10","key":"11227_CR32","doi-asserted-by":"publisher","first-page":"ofaa422","DOI":"10.1093\/ofid\/ofaa422","volume":"7","author":"AKJ Teo","year":"2020","unstructured":"Teo AKJ, Tan RKJ, Smyth C, Soltan V, Eng S, Ork C, Sok N, Tuot S, Hsu LY, Yi S. Characterizing and measuring tuberculosis stigma in the community: A Mixed-Methods study in Cambodia. Open Forum Infect Dis. 2020;7(10):ofaa422.","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"11227_CR33","doi-asserted-by":"publisher","first-page":"e0257379","DOI":"10.1371\/journal.pone.0257379","volume":"16","author":"O Zvonareva","year":"2021","unstructured":"Zvonareva O, Witte S, Kabanets N, Filinyuk O. Adolescents in a tuberculosis hospital: qualitative study of how relationships with doctors, caregivers, and peers mediate their mental wellbeing. PLoS ONE. 2021;16(10):e0257379.","journal-title":"PLoS ONE"},{"issue":"1","key":"11227_CR34","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/acs.analchem.4c04166","volume":"97","author":"L Zhang","year":"2025","unstructured":"Zhang L, Yu X, Zhang C, Zhang X, Huang H, Peng J. Development and comprehensive evaluation of Culture-Independent, long Amplicon-Based targeted Next-Generation sequencing methods for predicting antimicrobial resistance in tuberculosis. Anal Chem. 2025;97(1):281\u20139.","journal-title":"Anal Chem"},{"issue":"2","key":"11227_CR35","doi-asserted-by":"publisher","first-page":"134","DOI":"10.5588\/ijtld.20.0598","volume":"25","author":"E De Vos","year":"2021","unstructured":"De Vos E, Scott L, Voss De Lima Y, Warren RM, Stevens W, Hayes C, da Silva P, Van Rie A. Management of rifampicin-resistant TB: programme indicators and care cascade analysis in South Africa. Int J Tuberc Lung Dis. 2021;25(2):134\u201341.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"8","key":"11227_CR36","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1093\/jac\/dkt090","volume":"68","author":"D Machado","year":"2013","unstructured":"Machado D, Perdig\u00e3o J, Ramos J, Couto I, Portugal I, Ritter C, Boettger EC, Viveiros M. High-level resistance to Isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with InhA double mutations. J Antimicrob Chemother. 2013;68(8):1728\u201332.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"11227_CR37","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1086\/317598","volume":"182","author":"D van Soolingen","year":"2000","unstructured":"van Soolingen D, de Haas PE, van Doorn HR, Kuijper E, Rinder H, Borgdorff MW. Mutations at amino acid position 315 of the KatG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands. J Infect Dis. 2000;182(6):1788\u201390.","journal-title":"J Infect Dis"},{"key":"11227_CR38","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2147\/IDR.S242261","volume":"13","author":"R Charoenpak","year":"2020","unstructured":"Charoenpak R, Santimaleeworagun W, Suwanpimolkul G, Manosuthi W, Kongsanan P, Petsong S, Puttilerpong C. Association between the phenotype and genotype of Isoniazid resistance among Mycobacterium tuberculosis isolates in Thailand. Infect Drug Resist. 2020;13:627\u201334.","journal-title":"Infect Drug Resist"},{"issue":"10","key":"11227_CR39","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cmi.2020.07.004","volume":"26","author":"E Rivi\u00e8re","year":"2020","unstructured":"Rivi\u00e8re E, Whitfield MG, Nelen J, Heupink TH, Van Rie A. Identifying Isoniazid resistance markers to guide inclusion of high-dose Isoniazid in tuberculosis treatment regimens. Clin Microbiol Infect. 2020;26(10):1332\u20137.","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"11227_CR40","first-page":"1673","volume":"58","author":"C Wu","year":"2024","unstructured":"Wu C, Yang SJ, Lai WJ, Qu JX. [Clinical application of targeted next generation sequencing in detecting rifampicin and Rifabutin resistance in tuberculosis patients]. Zhonghua Yu Fang Yi Xue Za Zhi. 2024;58(11):1673\u20138.","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"11227_CR41","doi-asserted-by":"publisher","first-page":"105142","DOI":"10.1016\/j.meegid.2021.105142","volume":"96","author":"LL Rafael","year":"2021","unstructured":"Rafael LL, Raquel MS, Rogelio FA, Miroslava FP, Alejandra-Isabel JG, Paola RS. Discordant results between genotypic and phenotypic assays (Xpert MTB\/RIF vs. BACTEC MGIT 960 system) for detection of RIF-resistant Mycobacterium tuberculosis isolates in a high burden region. Infect Genet Evol. 2021;96:105142.","journal-title":"Infect Genet Evol"},{"issue":"6","key":"11227_CR42","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1073\/pnas.1919390117","volume":"117","author":"DL Huseby","year":"2020","unstructured":"Huseby DL, Brandis G, Praski Alzrigat L, Hughes D. Antibiotic resistance by high-level intrinsic suppression of a frameshift mutation in an essential gene. Proc Natl Acad Sci U S A. 2020;117(6):3185\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"11227_CR43","doi-asserted-by":"publisher","first-page":"e0085424","DOI":"10.1128\/aac.00854-24","volume":"68","author":"J Snobre","year":"2024","unstructured":"Snobre J, Meehan CJ, Mulders W, Rigouts L, Buyl R, de Jong BC, Van Rie A, Tzfadia O. Frameshift mutations in the mmpR5 gene can have a bedaquiline-susceptible phenotype by retaining a protein structure and function similar to wild-type Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2024;68(12):e0085424.","journal-title":"Antimicrob Agents Chemother"},{"key":"11227_CR44","doi-asserted-by":"publisher","first-page":"5655","DOI":"10.2147\/IDR.S375869","volume":"15","author":"HMA Hameed","year":"2022","unstructured":"Hameed HMA, Fang C, Liu Z, Ju Y, Han X, Gao Y, Wang S, Chiwala G, Tan Y, Guan P, et al. Characterization of genetic variants associated with rifampicin resistance level in Mycobacterium tuberculosis clinical isolates collected in Guangzhou chest hospital, China. Infect Drug Resist. 2022;15:5655\u201366.","journal-title":"Infect Drug Resist"},{"issue":"5","key":"11227_CR45","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jiph.2018.04.005","volume":"11","author":"MT Zaw","year":"2018","unstructured":"Zaw MT, Emran NA, Lin Z. Mutations inside rifampicin-resistance determining region of RpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis. J Infect Public Health. 2018;11(5):605\u201310.","journal-title":"J Infect Public Health"},{"issue":"3","key":"11227_CR46","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.diagmicrobio.2015.10.017","volume":"84","author":"Y Gu","year":"2016","unstructured":"Gu Y, Yu X, Jiang G, Wang X, Ma Y, Li Y, Huang H. Pyrazinamide resistance among multidrug-resistant tuberculosis clinical isolates in a National referral center of China and its correlations with pnca, rpsa, and pand gene mutations. Diagn Microbiol Infect Dis. 2016;84(3):207\u201311.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"11227_CR47","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1128\/JCM.01903-13","volume":"52","author":"Y Tan","year":"2014","unstructured":"Tan Y, Hu Z, Zhang T, Cai X, Kuang H, Liu Y, Chen J, Yang F, Zhang K, Tan S, et al. Role of PncA and RpsA gene sequencing in detection of Pyrazinamide resistance in Mycobacterium tuberculosis isolates from Southern China. J Clin Microbiol. 2014;52(1):291\u20137.","journal-title":"J Clin Microbiol"},{"key":"11227_CR48","doi-asserted-by":"publisher","first-page":"102013","DOI":"10.1016\/j.tube.2020.102013","volume":"125","author":"PW Ei","year":"2020","unstructured":"Ei PW, Mon AS, Htwe MM, Win SM, Aye KT, San LL, Zaw NN, Nyunt WW, Myint Z, Lee JS, et al. Pyrazinamide resistance and PncA mutations in drug resistant Mycobacterium tuberculosis clinical isolates from Myanmar. Tuberculosis (Edinb). 2020;125:102013.","journal-title":"Tuberculosis (Edinb)"},{"key":"11227_CR49","doi-asserted-by":"crossref","unstructured":"Naidoo K, Perumal R, Ngema SL, Shunmugam L, Somboro AM. Rapid diagnosis of Drug-Resistant Tuberculosis-Opportunities and challenges. Pathogens 2023, 13(1).","DOI":"10.3390\/pathogens13010027"},{"issue":"2","key":"11227_CR50","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/cid\/ciad596","volume":"78","author":"TS Brown","year":"2024","unstructured":"Brown TS, Tang L, Omar SV, Joseph L, Meintjes G, Maartens G, Wasserman S, Shah NS, Farhat MR, Gandhi NR, et al. Genotype-Phenotype characterization of serial Mycobacterium tuberculosis isolates in Bedaquiline-Resistant Tuberculosis. Clin Infect Dis. 2024;78(2):269\u201376.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"11227_CR51","doi-asserted-by":"publisher","first-page":"e0032222","DOI":"10.1128\/aac.00322-22","volume":"66","author":"E Rivi\u00e8re","year":"2022","unstructured":"Rivi\u00e8re E, Verboven L, Dippenaar A, Goossens S, De Vos E, Streicher E, Cuypers B, Laukens K, Ben-Rached F, Rodwell TC, et al. Variants in Bedaquiline-Candidate-Resistance genes: prevalence in Bedaquiline-Naive patients, effect on MIC, and association with Mycobacterium tuberculosis lineage. Antimicrob Agents Chemother. 2022;66(7):e0032222.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"11227_CR52","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5588\/ijtld.22.0138","volume":"27","author":"H Mansoor","year":"2023","unstructured":"Mansoor H, Hirani N, Chavan V, Das M, Sharma J, Bharati M, Oswal V, Iyer A, Morales M, Joshi A, et al. Clinical utility of target-based next-generation sequencing for drug-resistant TB. Int J Tuberc Lung Dis. 2023;27(1):41\u20138.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"11227_CR53","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12879-020-4802-9","volume":"20","author":"HJ Cho","year":"2020","unstructured":"Cho HJ, Lim YJ, Kim J, Koh WJ, Song CH, Kang MW. Different macrophage polarization between drug-susceptible and multidrug-resistant pulmonary tuberculosis. BMC Infect Dis. 2020;20(1):81.","journal-title":"BMC Infect Dis"},{"key":"11227_CR54","doi-asserted-by":"publisher","first-page":"113843","DOI":"10.1016\/j.ejmech.2021.113843","volume":"226","author":"S Consalvi","year":"2021","unstructured":"Consalvi S, Venditti G, Zhu J, Boshoff HI, Arora K, De Logu A, Ioerger TR, Rubin EJ, Biava M, Poce G. 6-Fluorophenylbenzohydrazides inhibit Mycobacterium tuberculosis growth through alteration of Tryptophan biosynthesis. Eur J Med Chem. 2021;226:113843.","journal-title":"Eur J Med Chem"},{"issue":"3","key":"11227_CR55","doi-asserted-by":"publisher","first-page":"e0061021","DOI":"10.1128\/Spectrum.00610-21","volume":"9","author":"HD Gliddon","year":"2021","unstructured":"Gliddon HD, Frampton D, Munsamy V, Heaney J, Pataillot-Meakin T, Nastouli E, Pym AS, Steyn AJC, Pillay D, McKendry RA. A rapid drug resistance genotyping workflow for Mycobacterium tuberculosis, using targeted isothermal amplification and nanopore sequencing. Microbiol Spectr. 2021;9(3):e0061021.","journal-title":"Microbiol Spectr"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11227-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11227-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11227-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:04:11Z","timestamp":1751414651000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11227-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11227"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11227-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"14 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received approval from the Human Research Ethics and System Review Committee of the Second Hospital of Nanjing (ID: 2024-LS-ky026). The study protocol was consistent with the ethical guidelines of the 1975 Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no conflict of interest to declare.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not Applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"861"}}